CHERYL TIOAQUEN: Open Payments
NPI 1740751973 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 15 payments from 10 companies in 2025. Trend: 2023 $3,994 · 2024 $4,496 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $155 |
| ABBVIE INC. | 2 | $47 |
| LEO Pharma Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $27 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| Organon LLC | 1 | $8 |
Products named: NEMLUVIO, ADBRY, COSENTYX, DUPIXENT, EBGLYSS, SKYRIZI, ILUMYA, SPEVIGO.
Industry payments across GA — which companies pay providers there.
